Associations between flavonoids and cardiovascular disease incidence or mortality in European and US populations

Nutrition Reviews

Volumn 70, Issue 9, 2012, Pages 491-508

  Peterson, Julia J ^a   Dwyer, Johanna T ^a,b   Jacques, Paul F ^a   Mccullough, Marjorie L ^c  

^a TUFTS UNIVERSITY   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c AMERICAN CANCER SOCIETY   (United States)

Author keywords

Cardiovascular disease; Coronary heart disease; Europe; Flavonoids; Prospective cohort studies; Stroke; United States

Indexed keywords

APIGENIN; CATECHIN; DAIDZEIN; DELPHINIDIN; EPICATECHIN; EPICATECHIN GALLATE; EPIGALLOCATECHIN; EPIGALLOCATECHIN GALLATE; ERIOCITRIN; FLAVONOID; GALLOCATECHIN; GENISTEIN; HESPERETIN; ISORHAMNETIN; KAEMPFEROL; LUTEOLIN; MALVIDIN CHLORIDE; MYRICETIN; NARINGENIN; PELARGONIDIN; PEONIDIN; PETUNIDIN CHLORIDE; QUERCETIN; UNCLASSIFIED DRUG;

ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; EUROPE; FINLAND; FOLLOW UP; HUMAN; ISCHEMIC HEART DISEASE; NETHERLANDS; OUTCOME ASSESSMENT; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; STROKE; UNITED STATES;

ANIMALS; CARDIOVASCULAR DISEASES; COHORT STUDIES; CROSS-CULTURAL COMPARISON; DIET; EUROPE; FLAVONOIDS; HUMANS; INCIDENCE; NUTRITIONAL STATUS; PROSPECTIVE STUDIES; UNITED STATES;

EID: 84865853940     PISSN: 00296643     EISSN: 17534887     Source Type: Journal    
DOI: 10.1111/j.1753-4887.2012.00508.x     Document Type: Article

References (175)

1. Crozier A, Jaganath IB, Clifford MN. Dietary phenolics: chemistry, bioavailability and effects on health. Nat Prod Rep. 2009;26:1001-1043.
2. Cassidy A, O'Reilly EJ, Kay C, etal. Habitual intake of flavonoid subclasses and incident hypertension in adults. Am J Clin Nutr. 2011;93:338-347.
3. Chun OK, Chung SJ, Song WO. Estimated dietary flavonoid intake and major food sources of U.S. adults. J Nutr. 2007;137:1244-1252.
4. Fink BN, Steck SE, Wolff MS, Kabat GC, Gammon MD. Construction of a flavonoid database for assessing intake in a population-based sample of women on Long Island, New York. Nutr Cancer. 2006;56:57-66.
5. Ovaskainen ML, Torronen R, Koponen JM, etal. Dietary intake and major food sources of polyphenols in Finnish adults. J Nutr. 2008;138:562-566.
6. Perez-Jimenez J, Fezeu L, Touvier M, etal. Dietary intake of 337 polyphenols in French adults. Am J Clin Nutr. 2011;93:1220-1228.
7. Song WO, Chun OK. Tea is the major source of flavan-3-ol and flavonol in the U.S. diet. J Nutr. 2008;138(Suppl):S1543-S1547.
8. Zamora-Ros R, Andres-Lacueva C, Lamuela-Raventos RM, etal. Estimation of dietary sources and flavonoid intake in a Spanish adult population (EPIC-Spain). J Am Diet Assoc. 2010;110:390-398.
9. Tribolo S, Lodi F, Connor C, etal. Comparative effects of quercetin and its predominant human metabolites on adhesion molecule expression in activated human vascular endothelial cells. Atherosclerosis. 2008;197:50-56.
10. Xia M, Ling W, Zhu H, etal. Anthocyanin attenuates CD40-mediated endothelial cell activation and apoptosis by inhibiting CD40-induced MAPK activation. Atherosclerosis. 2009;202:41-47.
11. Xia M, Ling W, Zhu H, etal. Anthocyanin prevents CD40-activated proinflammatory signaling in endothelial cells by regulating cholesterol distribution. Arterioscler Thromb Vasc Biol. 2007;27:519-524.
12. Kawai Y, Nishikawa T, Shiba Y, etal. Macrophage as a target of quercetin glucuronides in human atherosclerotic arteries: implication in the anti-atherosclerotic mechanism of dietary flavonoids. J Biol Chem. 2008;283:9424-9434.
13. Tu YC, Lian TW, Yen JH, etal. Antiatherogenic effects of kaempferol and rhamnocitrin. J Agric Food Chem. 2007;55:9969-9976.
14. Yamagata K, Miyashita A, Matsufuji H, etal. Dietary flavonoid apigenin inhibits high glucose and tumor necrosis factor alpha-induced adhesion molecule expression in human endothelial cells. J Nutr Biochem. 2010;21:116-124.
15. Arab L, Liebeskind DS. Tea, flavonoids and stroke in man and mouse. Arch Biochem Biophys. 2010;501:31-36.
16. Frei B, Higdon JV. Antioxidant activity of tea polyphenols in vivo: evidence from animal studies. J Nutr. 2003;133(Suppl):S3275-S3284.
17. Gandhi C, Upaganalawar A, Balaraman R. Protection against in vivo focal myocardial ischemia/reperfusion injury-induced arrhythmias and apoptosis by hesperidin. Free Radic Res. 2009;43:817-827.
18. Karthikeyan K, Bai BR, Devaraj SN. Efficacy of grape seed proanthocyanidins on cardioprotection during isoproterenol-induced myocardial injury in rats. J Cardiovasc Pharmacol. 2009;53:109-115.
19. Loke WM, Proudfoot JM, Hodgson JM, etal. Specific dietary polyphenols attenuate atherosclerosis in apolipoprotein E-knockout mice by alleviating inflammation and endothelial dysfunction. Arterioscler Thromb Vasc Biol. 2010;30:749-757.
20. Miyazaki K, Makino K, Iwadate E, etal. Anthocyanins from purple sweet potato Ipomoea batatas cultivar Ayamurasaki suppress the development of atherosclerotic lesions and both enhancements of oxidative stress and soluble vascular cell adhesion molecule-1 in apolipoprotein E-deficient mice. J Agric Food Chem. 2008;56:11485-11492.
21. Ramesh E, Geraldine P, Thomas PA. Regulatory effect of epigallocatechin gallate on the expression of C-reactive protein and other inflammatory markers in an experimental model of atherosclerosis. Chem Biol Interact. 2010;183:125-132.
22. Register TC. Primate models in women's health: inflammation and atherogenesis in female cynomolgus macaques (Macaca fascicularis). Am J Primatol. 2009;71:766-775.
23. Sheng R, Gu ZL, Xie ML, etal. EGCG inhibits proliferation of cardiac fibroblasts in rats with cardiac hypertrophy. Planta Med. 2009;75:113-120.
24. Tiwari R, Mohan M, Kasture S, etal. Cardioprotective potential of myricetin in isoproterenol-induced myocardial infarction in Wistar rats. Phytother Res. 2009;23:1361-1366.
25. Atteritano M, Marini H, Minutoli L, etal. Effects of the phytoestrogen genistein on some predictors of cardiovascular risk in osteopenic, postmenopausal women: a two-year randomized, double-blind, placebo-controlled study. J Clin Endocrinol Metab. 2007;92:3068-3075.
26. Aubertin-Leheudre M, Lord C, Khalil A, etal. Effect of 6 months of exercise and isoflavone supplementation on clinical cardiovascular risk factors in obese postmenopausal women: a randomized, double-blind study. Menopause. 2007;14:624-629.
27. Chong MF, Macdonald R, Lovegrove JA. Fruit polyphenols and CVD risk: a review of human intervention studies. Br J Nutr. 2010;104(Suppl 3):S28-S39.
28. Clerici C, Setchell KD, Battezzati PM, etal. Pasta naturally enriched with isoflavone aglycons from soy germ reduces serum lipids and improves markers of cardiovascular risk. J Nutr. 2007;137:2270-2278.
29. Greany KA, Nettleton JA, Wangen KE, etal. Consumption of isoflavone-rich soy protein does not alter homocysteine or markers of inflammation in postmenopausal women. Eur J Clin Nutr. 2008;62:1419-1425.
30. Hooper L, Kroon PA, Rimm EB, etal. Flavonoids, flavonoid-rich foods, and cardiovascular risk: a meta-analysis of randomized controlled trials. Am J Clin Nutr. 2008;88:38-50.
31. Jia L, Liu X, Bai YY, etal. Short-term effect of cocoa product consumption on lipid profile: a meta-analysis of randomized controlled trials. Am J Clin Nutr. 2010;92:218-225.
32. Marini H, Bitto A, Altavilla D, etal. Efficacy of genistein aglycone on some cardiovascular risk factors and homocysteine levels: a follow-up study. Nutr Metab Cardiovasc Dis. 2010;20:332-340.
33. Maskarinec G, Oum R, Chaptman AK, etal. Inflammatory markers in a randomized soya intervention among men. Br J Nutr. 2009;101:1740-1744.
34. Mulvihill EE, Huff MW. Antiatherogenic properties of flavonoids: implications for cardiovascular health. Can J Cardiol. 2010;26(Suppl A):17A-21A.
35. Oyama J, Maeda T, Kouzuma K, etal. Green tea catechins improve human forearm endothelial dysfunction and have antiatherosclerotic effects in smokers. Circ J. 2010;74:578-588.
36. Rios DR, Rodrigues ET, Cardoso AP, etal. Lack of effects of isoflavones on the lipid profile of Brazilian postmenopausal women. Nutrition. 2008;24:1153-1158.
37. Rotondo S, Krauze-Brzosko K, Manarini S, etal. Inhibition by soya isoflavones of human polymorphonuclear leukocyte function: possible relevance for the beneficial effects of soya intake. Br J Nutr. 2008;99:240-247.
38. Shenouda SM, Vita JA. Effects of flavonoid-containing beverages and EGCG on endothelial function. J Am Coll Nutr. 2007;26(Suppl):S366-S372.
39. Taku K, Umegaki K, Sato Y, etal. Soy isoflavones lower serum total and LDL cholesterol in humans: a meta-analysis of 11 randomized controlled trials. Am J Clin Nutr. 2007;85:1148-1156.
40. Villa P, Costantini B, Suriano R, etal. The differential effect of the phytoestrogen genistein on cardiovascular risk factors in postmenopausal women: relationship with the metabolic status. J Clin Endocrinol Metab. 2009;94:552-558.
41. Arts IC, Hollman PC. Polyphenols and disease risk in epidemiologic studies. Am J Clin Nutr. 2005;81(Suppl):S317-S325.
42. Cano A, Garcia-Perez MA, Tarin JJ. Isoflavones and cardiovascular disease. Maturitas. 2010;67:219-226.
43. de Lange DW, Verhoef S, Gorter G, etal. Polyphenolic grape extract inhibits platelet activation through PECAM-1: an explanation for the French paradox. Alcohol Clin Exp Res. 2007;31:1308-1314.
44. Erdman JW Jr, Carson L, Kwik-Uribe C, etal. Effects of cocoa flavanols on risk factors for cardiovascular disease. Asia Pac J Clin Nutr. 2008;17(Suppl 1):S284-S287.
45. Higdon JV, Frei B. Tea catechins and polyphenols: health effects, metabolism, and antioxidant functions. Crit Rev Food Sci Nutr. 2003;43:89-143.
46. Huntley AL. The health benefits of berry flavonoids for menopausal women: cardiovascular disease, cancer and cognition. Maturitas. 2009;63:297-301.
47. Kar P, Laight D, Shaw KM, etal. Flavonoid-rich grapeseed extracts: a new approach in high cardiovascular risk patients? Int J Clin Pract. 2006;60:1484-1492.
48. Landberg R, Sun Q, Rimm EB, etal. Selected dietary flavonoids are associated with markers of inflammation and endothelial dysfunction in U.S. women. J Nutr. 2011;141:618-625.
49. Manach C, Mazur A, Scalbert A. Polyphenols and prevention of cardiovascular diseases. Curr Opin Lipidol. 2005;16:77-84.
50. Middleton E Jr, Kandaswami C, Theoharides TC. The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer. Pharmacol Rev. 2000;52:673-751.
51. Rasmussen SE, Frederiksen H, Struntze Krogholm K, etal. Dietary proanthocyanidins: occurrence, dietary intake, bioavailability, and protection against cardiovascular disease. Mol Nutr Food Res. 2005;49:159-174.
52. Sacks FM, Lichtenstein A, Van Horn L, etal. Soy protein, isoflavones, and cardiovascular health: an American Heart Association Science Advisory for professionals from the Nutrition Committee. Circulation. 2006;113:1034-1044.
53. Sbarouni E, Iliodromitis EK, Zoga A, etal. The effect of the phytoestrogen genistein on myocardial protection and preconditioning in hypercholesterolemia. Cardiovasc Drugs Ther. 2007;21:399-400.
54. Basu A, Rhone M, Lyons TJ. Berries: emerging impact on cardiovascular health. Nutr Rev. 2010;68:168-177.
55. Erdman JW Jr, Balentine D, Arab L, etal. Flavonoids and heart health: proceedings of the ILSI North America Flavonoids Workshop, May 31-June 1, 2005, Washington, DC. J Nutr. 2007;137(Suppl 1):S718-S737.
56. Robbins RJ, Kwik-Uribe C, Hammerstone JF, etal. Analysis of flavanols in foods: what methods are required to enable meaningful health recommendations? J Cardiovasc Pharmacol. 2006;47(Suppl 2):S110-S118.
57. Rudkowska I. Functional foods for cardiovascular disease in women. Menopause Int. 2008;14:63-69.
58. Rudkowska I, Jones PJ. Functional foods for the prevention and treatment of cardiovascular diseases: cholesterol and beyond. Expert Rev Cardiovasc Ther. 2007;5:477-490.
59. Scheid L, Reusch A, Stehle P, etal. Antioxidant effects of cocoa and cocoa products ex vivo and in vivo: is there evidence from controlled intervention studies? Curr Opin Clin Nutr Metab Care. 2010;13:737-742.
60. Schroeter H, Heiss C, Spencer JP, etal. Recommending flavanols and procyanidins for cardiovascular health: current knowledge and future needs. Mol Aspects Med. 2010;31:546-557.
61. Sies H. Polyphenols and health: update and perspectives. Arch Biochem Biophys. 2010;501:2-5.
62. Steinberg FM, Bearden MM, Keen CL. Cocoa and chocolate flavonoids: implications for cardiovascular health. J Am Diet Assoc. 2003;103:215-223.
63. Arts IC, Hollman PC, Feskens EJ, etal. Catechin intake might explain the inverse relation between tea consumption and ischemic heart disease: the Zutphen Elderly Study. Am J Clin Nutr. 2001;74:227-232.
64. Arts IC, Jacobs DR Jr, Harnack LJ, etal. Dietary catechins in relation to coronary heart disease death among postmenopausal women. Epidemiology. 2001;12:668-675.
65. Geleijnse JM, Launer LJ, Van der Kuip DA, etal. Inverse association of tea and flavonoid intakes with incident myocardial infarction: the Rotterdam Study. Am J Clin Nutr. 2002;75:880-886.
66. Hertog MG, Feskens EJ, Hollman PC, etal. Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study. Lancet. 1993;342:1007-1011.
67. Hertog MG, Feskens EJ, Kromhout D. Antioxidant flavonols and coronary heart disease risk. Lancet. 1997;349:699.
68. Hertog MG, Sweetnam PM, Fehily AM, etal. Antioxidant flavonols and ischemic heart disease in a Welsh population of men: the Caerphilly Study. Am J Clin Nutr. 1997;65:1489-1494.
69. Hirvonen T, Pietinen P, Virtanen M, etal. Intake of flavonols and flavones and risk of coronary heart disease in male smokers. Epidemiology. 2001;12:62-67.
70. Hirvonen T, Virtamo J, Korhonen P, etal. Intake of flavonoids, carotenoids, vitamins C and E, and risk of stroke in male smokers. Stroke. 2000;31:2301-2306.
71. Keli SO, Hertog MG, Feskens EJ, etal. Dietary flavonoids, antioxidant vitamins, and incidence of stroke: the Zutphen study. Arch Intern Med. 1996;156:637-642.
72. Knekt P, Isotupa S, Rissanen H, etal. Quercetin intake and the incidence of cerebrovascular disease. Eur J Clin Nutr. 2000;54:415-417.
73. Knekt P, Jarvinen R, Reunanen A, etal. Flavonoid intake and coronary mortality in Finland: a cohort study. BMJ. 1996;312:478-481.
74. Knekt P, Kumpulainen J, Jarvinen R, etal. Flavonoid intake and risk of chronic diseases. Am J Clin Nutr. 2002;76:560-568.
75. Lin J, Rexrode KM, Hu F, etal. Dietary intakes of flavonols and flavones and coronary heart disease in US women. Am J Epidemiol. 2007;165:1305-1313.
76. Marniemi J, Alanen E, Impivaara O, etal. Dietary and serum vitamins and minerals as predictors of myocardial infarction and stroke in elderly subjects. Nutr Metab Cardiovasc Dis. 2005;15:188-197.
77. Mink PJ, Scrafford CG, Barraj LM, etal. Flavonoid intake and cardiovascular disease mortality: a prospective study in postmenopausal women. Am J Clin Nutr. 2007;85:895-909.
78. Mursu J, Voutilainen S, Nurmi T, etal. Flavonoid intake and the risk of ischemic stroke and CVD mortality in middle-aged Finnish men: the Kuopio Ischemic Heart Disease Risk Factor Study. Br J Nutr. 2008;100:890-895.
79. Rimm EB, Katan MB, Ascherio A, etal. Relation between intake of flavonoids and risk for coronary heart disease in male health professionals. Ann Intern Med. 1996;125:384-389.
80. Sesso HD, Gaziano JM, Liu S, etal. Flavonoid intake and the risk of cardiovascular disease in women. Am J Clin Nutr. 2003;77:1400-1408.
81. van der Schouw YT, Kreijkamp-Kaspers S, Peeters PH, etal. Prospective study on usual dietary phytoestrogen intake and cardiovascular disease risk in Western women. Circulation. 2005;111:465-471.
82. Yochum L, Kushi LH, Meyer K, etal. Dietary flavonoid intake and risk of cardiovascular disease in postmenopausal women. Am J Epidemiol. 1999;149:943-949.
83. Lagiou P, Samoli E, Lagiou A, etal. Intake of specific flavonoid classes and coronary heart disease - a case-control study in Greece. Eur J Clin Nutr. 2004;58:1643-1648.
84. Tavani A, Spertini L, Bosetti C, etal. Intake of specific flavonoids and risk of acute myocardial infarction in Italy. Public Health Nutr. 2006;9:369-374.
85. Willett W. Nutritional Epidemiology, 2nd ed. New York: Oxford University Press; 1998.
86. Hertog MG. Flavonols and flavones in foods and their relation with cancer and coronary heart disease risk. PhD dissertation. Koninklijke Bibliotheek, The Hague, 1994.
87. Hertog MGL, Hollman PCH, Katan MB. Content of potentially anticarcinogenic flavonoids of 28 vegetables and 9 fruits commonly consumed in the Netherlands. J Agric Food Chem. 1992;40:2379-2383.
88. Hertog MG, Hollman PC, Katan MB, etal. Intake of potentially anticarcinogenic flavonoids and their determinants in adults in The Netherlands. Nutr Cancer. 1993;20:21-29.
89. Hertog MGL, Hollman PCH, van de Putte B. Content of potentially anticarcinogenic flavonoids in tea infusions, wine and fruit juices. J Agric Food Chem. 1993;41:1242-1246.
90. Hertog MGL, Hollman PCH, Venema DP. Optimization of a quantitative HPLC determination of potentially anticarcinogenic flavonoids in vegetables and fruits. J Agric Food Chem. 1992;40:1591-1598.
91. Arts ICW, Hollman PCH. Optimization of a quantitative method for the determination of catechins in fruits and legumes. J Agric Food Chem. 1998;46:5156-5162.
92. Arts IC, van de Putte B, Hollman PC. Catechin contents of foods commonly consumed in The Netherlands. 1. Fruits, vegetables, staple foods, and processed foods. J Agric Food Chem. 2000;48:1746-1751.
93. Arts IC, van De Putte B, Hollman PC. Catechin contents of foods commonly consumed in The Netherlands. 2. Tea, wine, fruit juices, and chocolate milk. J Agric Food Chem. 2000;48:1752-1757.
94. Boker LK, Van der Schouw YT, De Kleijn MJ, etal. Intake of dietary phytoestrogens by Dutch women. J Nutr. 2002;132:1319-1328.
95. US Department of Agriculture. USDA Database for the Flavonoid Content of Selected Foods. Beltsville, MD: Agricultural Research Service, Nutrient Data Laboratory; 2003.
96. US Department of Agriculture. USDA-Iowa State University Database on the Isoflavone Content of Foods. Beltsville, MD: Agricultural Research Service, Nutrient Data Laboratory; 1999.
97. US Department of Agriculture. USDA database for the proanthocyanidin content of selected foods. Beltsville, MD: Agricultural Research Service, Nutrient Data Laboratory; 2004.
98. Hakkinen SH, Karenlampi SO, Heinonen IM, etal. Content of the flavonols quercetin, myricetin, and kaempferol in 25 edible berries. J Agric Food Chem. 1999;47:2274-2279.
99. Starke H, Herrmann K. Die phenolischen Inhaltsstoffe des Obstes. VIII. Veränderungen des Flavonolgehaltes während der Fruchtenwicklung. [The phenolics of fruits. VIII. Changes in flavonol concentrations during fruit development]. Z Lebensm Unters Forsch. 1976;161:131-135.
100. Wildanger W, Herrmann K. Die phenolischen Inhaltsstoffe des Obstes. II. Die Flavonole des Obstes [The phenolics of fruits. II. The flavonols of fruits]. Z Lebensm Unters Forsch. 1973;151:103-108.
101. Mattila P, Astola J, Kumpulainen J. Determination of flavonoids in plant material by HPLC with diode-array and electro-array detections. J Agric Food Chem. 2000;48:5834-5841.
102. Sampson L, Rimm E, Hollman PC, etal. Flavonol and flavone intakes in US health professionals. J Am Diet Assoc. 2002;102:1414-1420.
103. US Department of Agriculture, Agricultural Research Service. USDA Database for the Isoflavone Content of Selected Foods, Release 2.0. Beltsville, MD: Agricultural Research Service, Nutrient Data Laboratory; 2008.
104. US Department of Agriculture, Agricultural Research Service. USDA Database for the Flavonoid Content of Selected Foods, Release 3. Beltsville, MD: Agricultural Research Service, Nutrient Data Laboratory; 2011.
105. World Health Organization. Manual of the International Statistical Classification of Diseases, Injuries, and Causes of Death, 8th Revision. Geneva, Switzerland: WHO; 1965.
106. World Health Organization. Manual of the International Statistical Classification of Diseases, Injuries, and Causes of Death: Based on recommendations of the 9th revision conference, 1975, and adopted by the 29th World Health Assembly Geneva, Switzerland: WHO;1977.
107. World Health Organization. International Statistical Classification of Diseases and Related Health Problems, 10th Revision. Geneva, Switzerland: WHO; 1992.
108. Rose GA, Blackburn H. Cardiovascular Survey Methods. Geneva, Switzerland: WHO; 1982.
109. World Health Organization. Ischaemic Heart Disease Registers: Report of the Fifth Working Group, Including a Second Revision of the Operating Protocol: Copenhagen, 26-29 April 1971. Copenhagen: Regional Office for Europe, World Health Organization, 1971.
110. Huxley RR, Neil HA. The relation between dietary flavonol intake and coronary heart disease mortality: a meta-analysis of prospective cohort studies. Eur J Clin Nutr. 2003;57:904-908.
111. Messina M, Nagata C, Wu AH. Estimated Asian adult soy protein and isoflavone intakes. Nutr Cancer. 2006;55:1-12.
112. Hollman PC, Geelen A, Kromhout D. Dietary flavonol intake may lower stroke risk in men and women. J Nutr. 2010;140:600-604.
113. Geleijnse JM, Hollman PCH. Flavonoids and cardiovascular health: which compounds, what mechanisms? Am J Clin Nutr. 2008;88:12-13.
114. Yap S, Qin C, Woodman OL. Effects of resveratrol and flavonols on cardiovascular function: physiological mechanisms. Biofactors. 2010;36:350-359.
115. McCarty MF. Scavenging of peroxynitrite-derived radicals by flavonoids may support endothelial NO synthase activity, contributing to the vascular protection associated with high fruit and vegetable intakes. Med Hypotheses. 2008;70:170-181.
116. Zafra-Stone S, Yasmin T, Bagchi M, etal. Berry anthocyanins as novel antioxidants in human health and disease prevention. Mol Nutr Food Res. 2007;51:675-683.
117. Balzer J, Rassaf T, Heiss C, etal. Sustained benefits in vascular function through flavanol-containing cocoa in medicated diabetic patients a double-masked, randomized, controlled trial. J Am Coll Cardiol. 2008;51:2141-2149.
118. Bayard V, Chamorro F, Motta J, etal. Does flavanol intake influence mortality from nitric oxide-dependent processes? Ischemic heart disease, stroke, diabetes mellitus, and cancer in Panama. Int J Med Sci. 2007;4:53-58.
119. Cesarone MR, Di Renzo A, Errichi S, etal. Improvement in circulation and in cardiovascular risk factors with a proprietary isotonic bioflavonoid formula OPC-3. Angiology. 2008;59:408-414.
120. Farouque HM, Leung M, Hope SA, etal. Acute and chronic effects of flavanol-rich cocoa on vascular function in subjects with coronary artery disease: a randomized double-blind placebo-controlled study. Clin Sci. 2006;111:71-80.
121. Ghosh D, Scheepens A. Vascular action of polyphenols. Mol Nutr Food Res. 2009;53:322-331.
122. Vlachopoulos C, Alexopoulos N, Stefanadis C. Effect of dark chocolate on arterial function in healthy individuals: cocoa instead of ambrosia? Curr Hypertens Rep. 2006;8:205-211.
123. Webb CM, Hayward CS, Mason MJ, etal. Coronary vasomotor and blood flow responses to isoflavone-intact soya protein in subjects with coronary heart disease or risk factors for coronary heart disease. Clin Sci. 2008;115:353-359.
124. Booyse FM, Pan W, Grenett HE, etal. Mechanism by which alcohol and wine polyphenols affect coronary heart disease risk. Ann Epidemiol. 2007;17(Suppl):S24-S31.
125. de Gaetano G, De Curtis A, di Castelnuovo A, etal. Antithrombotic effect of polyphenols in experimental models: a mechanism of reduced vascular risk by moderate wine consumption. Ann N Y Acad Sci. 2002;957:174-188.
126. Maron DJ. Flavonoids for reduction of atherosclerotic risk. Curr Atheroscler Rep. 2004;6:73-78.
127. Ostertag LM, O'Kennedy N, Kroon PA, etal. Impact of dietary polyphenols on human platelet function - a critical review of controlled dietary intervention studies. Mol Nutr Food Res. 2010;54:60-81.
128. Garcia-Lafuente A, Guillamon E, Villares A, etal. Flavonoids as anti-inflammatory agents: implications in cancer and cardiovascular disease. Inflamm Res. 2009;58:537-552.
129. Heiss C, Schroeter H, Balzer J, etal. Endothelial function, nitric oxide, and cocoa flavanols. J Cardiovasc Pharmacol. 2006;47(Suppl 2):S128-S135.
130. Vita JA. Polyphenols and cardiovascular disease: effects on endothelial and platelet function. Am J Clin Nutr. 2005;81(Suppl):S292-S297.
131. Ishizawa K, Yoshizumi M, Kawai Y, etal. Pharmacology in health food: metabolism of quercetin in vivo and its protective effect against arteriosclerosis. J Pharmacol Sci. 2011;115:466-470.
132. Neveu V, Perez-Jimenez J, Vos F, etal. Phenol-Explorer: an online comprehensive database on polyphenol contents in foods. Database. 2010;doi:10.1093/database/bap024.
133. Gry J, Black L, Eriksen FD, etal. EuroFIR-BASIS - a combined composition and biological activity database for bioactive compounds in plant-based foods. Trends Food Sci Technol. 2007;18:434-444.
134. Cao J, Zhang Y, Chen W, etal. The relationship between fasting plasma concentrations of selected flavonoids and their ordinary dietary intake. Br J Nutr. 2010;103:249-255.
135. Linseisen J, Rohrmann S. Biomarkers of dietary intake of flavonoids and phenolic acids for studying diet-cancer relationship in humans. Eur J Nutr. 2008;47(Suppl 2):60-68.
136. Loke WM, Jenner AM, Proudfoot JM, etal. A metabolite profiling approach to identify biomarkers of flavonoid intake in humans. J Nutr. 2009;139:2309-2314.
137. Mennen LI, Sapinho D, Ito H, etal. Urinary excretion of 13 dietary flavonoids and phenolic acids in free-living healthy subjects - variability and possible use as biomarkers of polyphenol intake. Eur J Clin Nutr. 2008;62:519-525.
138. Perez-Jimenez J, Hubert J, Hooper L, etal. Urinary metabolites as biomarkers of polyphenol intake in humans: a systematic review. Am J Clin Nutr. 2010;92:801-809.
139. Scott EN, Gescher AJ, Steward WP, etal. Development of dietary phytochemical chemopreventive agents: biomarkers and choice of dose for early clinical trials. Cancer Prev Res. 2009;2:525-530.
140. Arai Y, Uehara M, Sato Y, etal. Comparison of isoflavones among dietary intake, plasma concentration and urinary excretion for accurate estimation of phytoestrogen intake. J Epidemiol. 2000;10:127-135.
141. Chan SG, Ho SC, Kreiger N, etal. Validation of a food frequency questionnaire for assessing dietary soy isoflavone intake among midlife Chinese women in Hong Kong. J Nutr. 2008;138:567-573.
142. Frankenfeld CL, Lampe JW, Shannon J, etal. Frequency of soy food consumption and serum isoflavone concentrations among Chinese women in Shanghai. Public Health Nutr. 2004;7:765-772.
143. Frankenfeld CL, Patterson RE, Horner NK, etal. Validation of a soy food-frequency questionnaire and evaluation of correlates of plasma isoflavone concentrations in postmenopausal women. Am J Clin Nutr. 2003;77:674-680.
144. Frankenfeld CL, Patterson RE, Kalhorn TF, etal. Validation of a soy food frequency questionnaire with plasma concentrations of isoflavones in US adults. J Am Diet Assoc. 2002;102:1407-1413.
145. French MR, Thompson LU, Hawker GA. Validation of a phytoestrogen food frequency questionnaire with urinary concentrations of isoflavones and lignan metabolites in premenopausal women. J Am Coll Nutr. 2007;26:76-82.
146. Heald CL, Bolton-Smith C, Ritchie MR, etal. Phyto-oestrogen intake in Scottish men: use of serum to validate a self-administered food-frequency questionnaire in older men. Eur J Clin Nutr. 2006;60:129-135.
147. Huang MH, Harrison GG, Mohamed MM, etal. Assessing the accuracy of a food frequency questionnaire for estimating usual intake of phytoestrogens. Nutr Cancer. 2000;37:145-154.
148. Jaceldo-Siegl K, Fraser GE, Chan J, etal. Validation of soy protein estimates from a food-frequency questionnaire with repeated 24-h recalls and isoflavonoid excretion in overnight urine in a Western population with a wide range of soy intakes. Am J Clin Nutr. 2008;87:1422-1427.
149. Kirk P, Patterson RE, Lampe J. Development of a soy food frequency questionnaire to estimate isoflavone consumption in US adults. J Am Diet Assoc. 1999;99:558-563.
150. Tseng M, Olufade T, Kurzer MS, etal. Food frequency questionnaires and overnight urines are valid indicators of daidzein and genistein intake in U.S. women relative to multiple 24-h urine samples. Nutr Cancer. 2008;60:619-626.
151. Verkasalo PK, Appleby PN, Allen NE, etal. Validation study of soya intake and plasma isoflavone levels among British women. IARC Sci Publ. 2002;156:135-136.
152. Williams AE, Maskarinec G, Hebshi S, etal. Validation of a soy questionnaire with repeated dietary recalls and urinary isoflavone assessments over one year. Nutr Cancer. 2003;47:118-125.
153. Yamamoto S, Sobue T, Sasaki S, etal. Validity and reproducibility of a self-administered food-frequency questionnaire to assess isoflavone intake in a Japanese population in comparison with dietary records and blood and urine isoflavones. J Nutr. 2001;131:2741-2747.
154. Hakim IA, Hartz V, Harris RB, etal. Reproducibility and relative validity of a questionnaire to assess intake of black tea polyphenols in epidemiological studies. Cancer Epidemiol Biomarkers Prev. 2001;10:667-678.
155. Mullie P, Clarys P, Deriemaeker P, etal. Estimation of daily human intake of food flavonoids. Plant Foods Hum Nutr. 2007;62:93-98.
156. Ranka S, Gee JM, Biro L, etal. Development of a food frequency questionnaire for the assessment of quercetin and naringenin intake. Eur J Clin Nutr. 2008;62:1131-1138.
157. Brantsaeter AL, Haugen M, Rasmussen SE, etal. Urine flavonoids and plasma carotenoids in the validation of fruit, vegetable and tea intake during pregnancy in the Norwegian Mother and Child Cohort Study (MoBa). Public Health Nutr. 2007;10:838-847.
158. Mikkelsen TB, Olsen SF, Rasmussen SE, etal. Relative validity of fruit and vegetable intake estimated by the food frequency questionnaire used in the Danish National Birth Cohort. Scand J Public Health. 2007;35:172-179.
159. Zhang Y, Li Y, Cao C, etal. Dietary flavonol and flavone intakes and their major food sources in Chinese adults. Nutr Cancer. 2010;62:1120-1127.
160. Kokubo Y, Iso H, Ishihara J, etal. Association of dietary intake of soy, beans, and isoflavones with risk of cerebral and myocardial infarctions in Japanese populations: the Japan Public Health Center-based (JPHC) study cohort I. Circulation. 2007;116:2553-2562.
161. Nagata C. Ecological study of the association between soy product intake and mortality from cancer and heart disease in Japan. Int J Epidemiol. 2000;29:832-836.
162. Desch S, Schmidt J, Kobler D, etal. Effect of cocoa products on blood pressure: systematic review and meta-analysis. Am J Hypertens. 2010;23:97-103.
163. Perez-Vizcaino F, Duarte J, Jimenez R, etal. Antihypertensive effects of the flavonoid quercetin. Pharmacol Rep. 2009;61:67-75.
164. Phang M, Lazarus S, Wood LG, etal. Diet and thrombosis risk: nutrients for prevention of thrombotic disease. Semin Thromb Hemost. 2011;37:199-208.
165. Akazome Y, Kametani N, Kanda T, etal. Evaluation of safety of excessive intake and efficacy of long-term intake of beverages containing apple polyphenols. J Oleo Sci. 2010;59:321-338.
166. Basu A, Wilkinson M, Penugonda K, etal. Freeze-dried strawberry powder improves lipid profile and lipid peroxidation in women with metabolic syndrome: baseline and post intervention effects. Nutr J. 2009;8:43.
167. Daniele C, Mazzanti G, Pittler MH, etal. Adverse-event profile of Crataegus spp.: a systematic review. Drug Saf. 2006;29:523-535.
168. Galati G, O'Brien PJ. Potential toxicity of flavonoids and other dietary phenolics: significance for their chemopreventive and anticancer properties. Free Radic Biol Med. 2004;37:287-303.
169. Munro IC, Harwood M, Hlywka JJ, etal. Soy isoflavones: a safety review. Nutr Rev. 2003;61:1-33.
170. Prasain JK, Carlson SH, Wyss JM. Flavonoids and age-related disease: risk, benefits and critical windows. Maturitas. 2010;66:163-171.
171. Schonthal AH. Adverse effects of concentrated green tea extracts. Mol Nutr Food Res. 2011;55:874-885.
172. Song WO, Chun OK, Hwang I, etal. Soy isoflavones as safe functional ingredients. J Med Food. 2007;10:571-580.
173. Wuttke W, Jarry H, Seidlova-Wuttke D. Isoflavones - safe food additives or dangerous drugs? Ageing Res Rev. 2007;6:150-188.
174. Bast A, Haenen GR, Bruynzeel AM, etal. Protection by flavonoids against anthracycline cardiotoxicity: from chemistry to clinical trials. Cardiovasc Toxicol. 2007;7:154-159.
175. Chan YH, Lau KK, Yiu KH, etal. Reduction of C-reactive protein with isoflavone supplement reverses endothelial dysfunction in patients with ischaemic stroke. Eur Heart J. 2008;29:2800-2807.